💨 Abstract
Lyell Immunopharma Inc. reported a second-quarter loss of $42.7 million, equivalent to $2.89 per share. The South San Francisco-based biotech company generated minimal revenue of $8,000 during the period. This financial update was provided through an automated report using data from Zacks Investment Research.
Courtesy: WTOP Staff
Suggested
Judge to hear arguments on halting ‘Alligator Alcatraz’ construction over environmental concerns -
Venus Williams gets a US Open wild card at age 45 and will be the oldest in singles since 1981 -
Venus Williams gets a wild-card entry to play singles at the US Open at age 45 -
Charlie Brown and Snoopy offer an animated ‘Peanuts’ musical about summer camp -
David Booth’s $300 million gift to Kansas: How it will transform the stadium and Gateway District -
290 DC-area companies make the new Inc. 5000 list -
German Chancellor Friedrich Merz says European leaders and Zelenskyy had ‘constructive’ meeting with Trump about Ukraine -
Gang members release 11 guards held hostage in Guatemalan prisons -
Siguen audiencias sobre si detener construcciones en “Alligator Alcatraz” por razones ambientales
Thomas Müller jokes he’s missing Manuel Neuer as Vancouver adventure begins -